81 FR 11816 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 44 (March 7, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 44 (March 7, 2016)
| Page Range | 11816-11816 | |
| FR Document | 2016-04915 |
[Federal Register Volume 81, Number 44 (Monday, March 7, 2016)] [Notices] [Page 11816] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-04915] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Bioreactors for Reparative Medicine (STTR). Date: March 24, 2016. Time: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Tony L Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892-7924, 301-435-0725, [email protected]. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Bioreactors for Reparative Medicine (SBIR). Date: March 24, 2016. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Tony L Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892-7924, 301-435-0725, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: March 1, 2016. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-04915 Filed 3-4-16; 8:45 am] BILLING CODE 4140-01-P
![11816 Federal Register / Vol. 81, No. 44 / Monday, March 7, 2016 / Notices
The Health Center Controlled Network operational quality, including their plans to meet goals for the next year.
(HCCN) Program serves as a major obtaining of Patient Centered Medical Grantees submit their work plan
component of HRSA’s HIT initiative to Home (PCMH) recognition. updates and annual, non-competing
support these goals. The HCCN model HRSA collects and evaluates network continuation progress reports each fiscal
focuses on the integration of certain outcome measures. HRSA requires that year of the grant; the submission and
functions and the sharing of skills, HCCNs report such measures to HRSA subsequent HRSA approval of each
resources, and data to improve health in annual work plan updates as part of report triggers the budget period
center operations and care provision, their annual, non-competing renewal and release of each subsequent
and generating efficiencies and continuation progress reports through year of funding.
economies of scale. Through this grant, an electronic reporting system. The Burden Statement: Burden in this
HCCNs will provide support for the work plan includes information on context means the time expended by
adoption and implementation of HIT, grantees’ plans and progress on the persons to generate, maintain, retain,
including meaningful use of EHRs, to following: disclose or provide the information
improve the quality of care provided by • Adoption and Implementation of requested. This includes the time
existing Health Center Program grantees HIT (including EHR); needed to review instructions, to
(i.e., Section 330 funded health centers) • Attainment of Meaningful Use develop, acquire, install and utilize
by engaging in the following program Requirements; and technology and systems for the purpose
components: • Improvement of quality measures of collecting, validating and verifying
• Adoption and Implementation: (e.g., Healthy People 2020 clinical information, processing and
Assist participating health centers with quality measures, PCMH recognition maintaining information, and disclosing
effectively adopting and implementing status, etc.). and providing information, to train
certified EHR technology. The annual, non-competing personnel and to be able to respond to
• Meaningful Use: Support continuation progress reports describe a collection of information, to search
participating health centers in meeting each grantee’s progress in achieving key data sources, to complete and review
Meaningful Use requirements and activity goals such as quality the collection of information, and to
accessing incentive payments under the improvement, data access and exchange, transmit or otherwise disclose the
Medicare and Medicaid Electronic efficiency and effectiveness of network information. The total annual burden
Health Records Incentive Programs. services, and the ability to track and hours estimated for this ICR are
• Quality Improvement (QI): Advance monitor patient outcomes, as well as summarized in the table below.
participating health centers’ QI emerging needs, challenges and barriers The annual estimate of burden is as
initiatives to improve clinical and encountered customer satisfaction, and follows:
Responses
Number of Total Hours per Total burden
Form name per
respondents responses response hours
respondent
Work Plan Update .............................................................. 43 1 43 10.9 468.7
Annual Progress Report .................................................... 43 1 43 44.5 1913.5
Total ............................................................................ 86 .......................... ........................ ........................ 2382.2
Jackie Painter, applications, the disclosure of which Contact Person: Tony L Creazzo, Ph.D.,
Director, Division of the Executive Secretariat. would constitute a clearly unwarranted Scientific Review Officer, Office of Scientific
[FR Doc. 2016–04984 Filed 3–4–16; 8:45 am] invasion of personal privacy. Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
BILLING CODE 4165–15–P Name of Committee: National Heart, Lung,
7180, Bethesda, MD 20892–7924, 301–435–
and Blood Institute Special Emphasis Panel;
Bioreactors for Reparative Medicine (STTR). 0725, creazzotl@mail.nih.gov.
DEPARTMENT OF HEALTH AND Date: March 24, 2016. (Catalogue of Federal Domestic Assistance
HUMAN SERVICES Time: 1:00 p.m. to 2:00 p.m. Program Nos. 93.233, National Center for
Agenda: To review and evaluate grant Sleep Disorders Research; 93.837, Heart and
National Institutes of Health applications. Vascular Diseases Research; 93.838, Lung
Place: National Institutes of Health, 6701 Diseases Research; 93.839, Blood Diseases
National Heart, Lung, and Blood Rockledge Drive, Room 7180, Bethesda, MD and Resources Research, National Institutes
Institute; Notice of Closed Meetings 20892, (Telephone Conference Call).
of Health, HHS)
Contact Person: Tony L Creazzo, Ph.D.,
Pursuant to section 10(d) of the Scientific Review Officer, Office of Scientific Dated: March 1, 2016.
Federal Advisory Committee Act, as Review/DERA, National Heart, Lung, and Michelle Trout,
amended (5 U.S.C. App.), notice is Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435– Program Analyst, Office of Federal Advisory
hereby given of the following meetings. Committee Policy.
The meetings will be closed to the 0725, creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung, [FR Doc. 2016–04915 Filed 3–4–16; 8:45 am]
public in accordance with the
asabaliauskas on DSK3SPTVN1PROD with NOTICES
provisions set forth in sections and Blood Institute Special Emphasis Panel; BILLING CODE 4140–01–P
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Bioreactors for Reparative Medicine (SBIR).
Date: March 24, 2016.
as amended. The grant applications and
Time: 2:00 p.m. to 5:00 p.m.
the discussions could disclose Agenda: To review and evaluate grant
confidential trade secrets or commercial applications.
property such as patentable material, Place: National Institutes of Health, 6701
and personal information concerning Rockledge Drive, Room 7180, Bethesda, MD
individuals associated with the grant 20892, (Telephone Conference Call).
VerDate Sep<11>2014 18:37 Mar 04, 2016 Jkt 238001 PO 00000 Frm 00079 Fmt 4703 Sfmt 9990 E:\FR\FM\07MRN1.SGM 07MRN1](https://thefederalregister.org/doc/81_FR_11860/page/1.svg)
Document Created: 2018-02-02 15:08:13
Document Modified: 2018-02-02 15:08:13
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | March 24, 2016. | |
| FR Citation | 81 FR 11816 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR